Co-Authors
This is a "connection" page, showing publications co-authored by Lars Køber and Henning Bundgaard.
Connection Strength
0.823
-
Long-Term Outcomes of Partial Oral Treatment of Endocarditis. N Engl J Med. 2019 04 04; 380(14):1373-1374.
Score: 0.203
-
Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis. N Engl J Med. 2019 01 31; 380(5):415-424.
Score: 0.196
-
Response letter to "Cardiac involvement in myotonic dystrophy type 1--do not forget the loop recorder!". Int J Cardiol. 2013 Sep 30; 168(2):1541.
Score: 0.132
-
Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study. Eur Heart J. 2019 10 14; 40(39):3237-3244.
Score: 0.053
-
Incidence of infective endocarditis in patients considered at moderate risk. Eur Heart J. 2019 05 01; 40(17):1355-1361.
Score: 0.051
-
Cardiac implantable electronic device and associated risk of infective endocarditis in patients undergoing aortic valve replacement. Europace. 2018 10 01; 20(10):e164-e170.
Score: 0.049
-
Incidence of infective endocarditis among patients considered at high risk. Eur Heart J. 2018 02 14; 39(7):623-629.
Score: 0.047
-
Temporal changes in infective endocarditis guidelines during the last 12 years: High-level evidence needed. Am Heart J. 2017 Nov; 193:70-75.
Score: 0.045
-
Echocardiographic and clinical findings in patients with Fabry disease during long-term enzyme replacement therapy: a nationwide Danish cohort study. Scand Cardiovasc J. 2017 Aug; 51(4):207-216.
Score: 0.045